rovalpituzumab tesirine,gilteritinib,crovalimab,eculizumab
abbvie,astellas,astrazeneca,chugai pharmaceutical,roche
['commodore 1', 'commodore ', 'crovalimab', 'rova,(-approval),(-microvascular)', 'roche,(-broche),(-rocheter)']
the chugai/roche antibody has been filed for pnh in japan as more details of its phase iii commodore 1/2 results are released. #pharma
crovalimab filed in japan as more phase iii results released at eha 
Managing Editor, Japan for @PharmaScrip and @PharmaPinkSheet . All views are my own. 製薬業界向け英字媒体Scrip、Pink Sheetの日本担当マネージングエディター。時々日本語で投稿します